Clinical Complete Response Rate With Negative MRD

1 clinical trials · Condition

Record	Firm	Date
The Efficacy of Watch and Wait Strategy or Surgery After Neoadjuvant Immunotherapy for Locally Advanced Colorectal Cancer With dMMR/MSI-H Guided by MRD Dynamic Monitoring: A Single-center, Open-label, Prospective, Phase II Clinical Trial. (NCT06477991)	Yunnan Cancer Hospital	2023-10-30

Every clearance here is in the API, with alerts when new ones post.